REX REX AMERICAN RESOURCES Corp
Industrial Organic Chemicals · NYSE · SEC CIK 744187 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.3%
TTM net income YoY114.0%
TTM EPS YoY334.5%
Revenue 3-yr CAGR-8.0%
Net income 3-yr CAGR71.3%
Margins
Gross margin22.4%
Operating margin—
Net margin20.9%
FCF margin10.4%
EBITDA margin—
Returns
ROE22.5%
ROA17.6%
ROIC (approx.)—
Asset turnover0.85x
Leverage & solvency
Liabilities / assets9.9%
Debt / equity0.00x
Current ratio6.88x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.04x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue11.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2026-01-31 | FY2024*2025-01-31 | FY20242024-01-31 | FY20222023-01-31 | FY20222022-01-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $650.49M | $642.49M | $833.38M | $855.00M | $774.80M |
| Cost of revenue | $556.78M | $551.01M | $735.17M | $806.40M | $684.17M |
| Gross profit | $93.71M | $91.48M | $98.22M | $48.60M | $90.63M |
| SG&A expense | $32.62M | $27.15M | $29.38M | $22.83M | $21.55M |
| Pretax income | — | $92.87M | $98.48M | $47.48M | $75.84M |
| Income tax | -$6.50M | $21.39M | $22.56M | $9.54M | $19.03M |
| Net income | $95.07M | $71.49M | $60.94M | $27.70M | $52.36M |
| EPS (basic) | 2.50 | 1.65 | 1.74 | 1.57 | 2.92 |
| EPS (diluted) | 2.50 | 1.65 | 1.73 | 1.57 | 2.92 |
| Weighted avg. shares (diluted) | 33.21M | 35.27M | 35.15M | 17.64M | 17.95M |
| Balance sheet | |||||
| Cash & equivalents | $188.73M | $196.25M | $223.40M | $71.35M | $232.07M |
| Short-term investments | $187.05M | $162.82M | $155.26M | $211.33M | $25.88M |
| Receivables | $14.68M | $21.50M | $23.20M | $25.16M | $25.82M |
| Inventory | $28.42M | $31.68M | $26.98M | $48.74M | $42.23M |
| Current assets | $447.83M | $435.82M | $452.10M | $372.64M | $345.17M |
| PP&E, net | $272.03M | $210.68M | $155.59M | $135.50M | $137.55M |
| Total assets | $797.73M | $720.01M | $664.80M | $579.58M | $550.36M |
| Current liabilities | $75.38M | $50.44M | $66.26M | $54.60M | $50.48M |
| Total liabilities | $95.73M | $76.41M | $77.20M | $68.58M | $62.80M |
| Shareholders' equity | $610.71M | $560.34M | $513.92M | $447.98M | $430.79M |
| Shares outstanding | 32.94M | 34.39M | 17.50M | 17.39M | 17.76M |
| Cash flow statement | |||||
| Operating cash flow | $117.83M | $64.19M | $127.97M | $54.80M | $91.71M |
| Capital expenditure | $68.44M | $71.32M | $37.66M | $15.58M | $5.13M |
| Free cash flow | $49.39M | -$7.13M | $90.31M | $39.22M | $86.58M |
| Investing cash flow | -$87.69M | -$72.86M | $28.40M | -$198.51M | $5.29M |
| Financing cash flow | -$37.66M | -$18.47M | -$4.32M | -$17.01M | -$11.10M |
| Depreciation & amortization | $15.34M | $15.93M | $17.79M | $17.98M | $18.03M |
| Stock-based compensation | $4.21M | $3.64M | $6.21M | $1.93M | $1.75M |
| Share buybacks | $33.38M | $14.74M | $0 | $13.01M | $6.63M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.